je.st
news
Novartis Wins FDA Approval For Zarxio, First Biosimilar Drug In The US
2015-03-06 22:24:27| Biotech - Topix.net
U.S. regulators on Friday gave a green light to sales of the country's first copied version of a biotechnology drug, or "biosimilar," with approval of Novartis' white blood cell-boosting Zarxio. The drug contains the same active ingredient as Neupogen, or filgrastim, which logged 2014 worldwide sales of $1.2 billion for manufacturer Amgen.
Tags: the
us
drug
approval
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|
|||